Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.24M P/E - EPS this Y 26.00% Ern Qtrly Grth -
Income -16.69M Forward P/E -2.01 EPS next Y 23.10% 50D Avg Chg -19.00%
Sales 9.15M PEG - EPS past 5Y - 200D Avg Chg -51.00%
Dividend N/A Price/Book 25.76 EPS next 5Y - 52W High Chg -85.00%
Recommedations 2.70 Quick Ratio 0.79 Shares Outstanding 12.34M 52W Low Chg 10.00%
Insider Own 38.84% ROA -99.70% Shares Float 9.36M Beta 1.61
Inst Own 9.09% ROE -723.45% Shares Shorted/Prior 134.16K/170.02K Price 2.55
Gross Margin 57.48% Profit Margin -182.33% Avg. Volume 47,450 Target Price 5.25
Oper. Margin -194.13% Earnings Date May 9 Volume 34,909 Change -3.41%
About Aspira Women's Health Inc.

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

Aspira Women's Health Inc. News
04/09/24 Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
03/28/24 Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
03/25/24 Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
03/21/24 Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
03/18/24 Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President
03/11/24 Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
02/22/24 Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
02/12/24 Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)
02/06/24 Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines
01/25/24 Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement
01/25/24 OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
01/04/24 Bullish Aspira Women's Health Insiders Loaded Up On US$702.9k Of Stock
12/19/23 Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024
12/14/23 Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
12/08/23 New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT
12/07/23 New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
12/06/23 Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
11/28/23 Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
11/27/23 Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)
11/13/23 Aspira Women’s Health Reports Third Quarter 2023 Financial Results
AWH Chatroom

User Image Goldminecanary12 Posted - 9 hours ago

$AWH If only there was a company somewhere that was actually worth a fk…Let’s go, Nicole. Let’s add those 25 OVA tests yoy.

User Image PyraWeb Posted - 1 day ago

$AWH PyraWeb daily. 3.57 has been tapped, but not exceeded. Gap at 3.11. And today gapped down, and filled…and the fact it didn’t close over 3.57, again, leads me back to the 3.11.

User Image Dyslexiclad Posted - 2 days ago

$AWH mmm imma hold off for now I agree with the robot

User Image PyraWeb Posted - 2 days ago

$AWH atm today is a dark cloud cover pattern because it gapped up, and it’s fallen more than 50% of Fridays candle. Volume is measly. 3.11 is the gap nearby.

User Image PyraWeb Posted - 5 days ago

$AWH wow it’s really moving up! But the volume is nothing so I’m expecting end of day games for lower close, and I see it filling gap early next week, maybe today. I might look at it differently if this candle today moved on high volume. 🦆 PyraWeb

User Image RallyRaider Posted - 5 days ago

$AWH sees some accumulation, is strong. Last time it went sub 3, smart insiders bought and it 2x

User Image PyraWeb Posted - 1 week ago

$AWH it is subtle but a gap was made on todays candle. If it’s a mid wave gap that would put 3.57 as local high, and potential test over. The candle has a shooting star form though, either way, I’d expect 3.11 to get tagged again. I’d rather close it sooner than after touching 3.57, but that’s just me. PyraWeb 🌈🕸📐

User Image RallyRaider Posted - 1 week ago

$AWH Last time it went sub 3, smart insiders bought stock and it 2xed. can make lots of money in endo + ovarian

User Image JumboMike Posted - 1 week ago

$AWH well short interest keeps coming down. Will see if it matters. https://www.nasdaq.com/market-activity/stocks/awh/short-interest

User Image PyraWeb Posted - 1 week ago

$AWH ahh news and price is back over Thales line. With price back over with good volume, it should test 3.57… it’s a level that price absolutely needs to get past. This POS has been run into the ground, it is of the utmost importance to start making technical progress or this thing is f done, 3.57 is the first major test.

User Image Stock_Titan Posted - 1 week ago

$AWH Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California https://www.stocktitan.net/news/AWH/aspira-women-s-health-announces-anthem-blue-cross-to-provide-azs6wo9ubc13.html

User Image PyraWeb Posted - 1 week ago

$AWH Price has bounced a little today and the wick of todays candle starts above the Thales line meaning Thales line may be holding this down…price needs to exceed at close or its just a test resistance from below confirm continuation.

User Image RallyRaider Posted - 1 week ago

$AWH they seem confident in more coverage. Can win big in ovarian and endometriosis Last time it went here, Schuler loaded some and it went 2x.

User Image PyraWeb Posted - 1 week ago

$AWH PyraWeb, the breakdown at 3.57 was bad, but now the next chamber down is .6193, AND their now selling shares at the low of a quadruple low point… awesome moves Nicole!

User Image DonCorleone77 Posted - 1 week ago

$AWH Aspira Women's Health files to sell 1.57M shares of common stock for holders

User Image JumboMike Posted - 1 week ago

$AWH what's the next big announcement? A new Director or hot shot making $350K a year or Nicole stumbling and bumbling through another presentation at a Healthcare conference? Can you imagine when a big player in Healthcare looks at her profile and finds out she is an auditor for a big accounting firm and adheres to the DEI standards of hiring? Fire Nicole I've seen enough. I started the Fire Val campaign but it took 2+ years before it came to fruition. She needs to go right away.

User Image JumboMike Posted - 2 weeks ago

$AWH Actually short interest went down and not up! https://www.nasdaq.com/market-activity/stocks/awh/short-interest

User Image JumboMike Posted - 2 weeks ago

$AWH last short count we increased shares short by 15% which is a large amount. Will be interesting what the EOQ numbers look like. Probably released around the 10th of April.

User Image lecorb Posted - 2 weeks ago


User Image Goldminecanary12 Posted - 2 weeks ago

$AWH This pre split or post split? Jesus. Hilarious.

User Image Goldminecanary12 Posted - 03/28/24

$AWH Great work team! Garbage OVA sales for years, no ENDO launch in ‘23 as was touted since ‘22. You know, for an educated group in here, the calls that this isn’t going lower after earnings or after the last stock sale “because it was a placement” seem a bit naive lol Guess I’ll add under $2. If ‘23 was our year “as per Nicole” then ‘24 should be the nail in the coffin. ENDO launch in 3024 baby!

User Image PyraWeb Posted - 03/28/24

$AWH someone putting in work on this 3.57 line…someone doesn’t want price to be above it, maybe because I mentioned it.…and while price is below it I’m just expecting we see .6193-2.00. It’s still close enough it can pop back over 3.57, but if it gets a bit further away… ☠️

User Image JumboMike Posted - 03/28/24

$AWH ok fell asleep reading the release, if Nicole said anything important on the call please share! Thanks in advance and got what I expected a big so what report!

User Image DonCorleone77 Posted - 03/28/24

$AWH Aspira Women's Health reports Q4 EPS (30c), consensus (45c) Reports Q4 revenue $2.13M, consensus $2.54M. "We made a great deal of progress in 2023. Not only were we able to cut our cash used in operations in half by aligning spending to business needs, but we simultaneously increased revenues and test volume, implemented enhancements to our commercial organization and achieved important market access milestones," said Nicole Sandford, Chief Executive Officer of Aspira. "Progress in our innovation program continued to accelerate with the announcement in December of the first ever proteomic blood test to identify endometriomas and the achievement of major milestones in the development of our promising AI-enabled protein and miRNA diagnostic tests for ovarian cancer and endometriosis."

User Image epsguid Posted - 03/28/24

$AWH reported a loss of $0.30, consensus was ($0.39) via @eWhispers #epsbeat http://eps.sh/d/awh

User Image Goldminecanary12 Posted - 03/28/24

$AWH Great job, team. Stellar performance as usual. Think we ought to bump Nicole to $650k per year. Worth every penny.

User Image Stock_Titan Posted - 03/28/24

$AWH Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/AWH/aspira-women-s-health-reports-fourth-quarter-and-full-year-2023-to61dompn48y.html

User Image JumboMike Posted - 03/25/24

$AWH honestly who announces the day before Good Friday? This can't be good that they waited the entire 90 days allotted for EOY results. 45 days in the maximum for Q1, 2 & 3. Your granted more time for Q4 EOY.

User Image Stock_Titan Posted - 03/25/24

$AWH Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call https://www.stocktitan.net/news/AWH/aspira-women-s-health-announces-new-time-for-its-fourth-quarter-and-kl834ivpqzhl.html

User Image PyraWeb Posted - 03/21/24

$AWH PyraWeb today’s candle tapped the yellow chamber, and is now identifying as gravestone doji right around 3.57, and a near gap below that needs filling.

Analyst Ratings
Cantor Fitzgerald Neutral Apr 10, 24
Cantor Fitzgerald Neutral Apr 1, 24
Cantor Fitzgerald Neutral Sep 26, 23
Alliance Global Partners Buy Aug 22, 23
Cantor Fitzgerald Neutral May 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Merchant Minh Hoang Secretary & General.. Secretary & General Counsel Dec 06 Sell 3.37 980 3,303 12/08/23
Sandford Nicole President & CEO President & CEO Dec 06 Buy 3.36 5,000 16,800 58,703 12/06/23
Hombeck Torsten Chief Financial Offi.. Chief Financial Officer Sep 08 Buy 4.3 2,246 9,658 3,000 09/12/23
Fralick Celeste Rachelle Director Director Jul 24 Buy 3.98 754 3,001 12,032 07/26/23
Vos Ellen O'Connor Director Director Jul 24 Buy 3.98 3,769 15,001 32,878 07/26/23
SCHULER JACK W 10% Owner 10% Owner Jul 24 Buy 2.75 181,800 499,950 1,883,656 07/25/23
Cavanaugh Stefanie L. Director Director Jul 24 Buy 3.98 6,281 24,998 34,904 07/25/23
Sandford Nicole President & CEO President & CEO Jul 24 Buy 3.98 12,563 50,001 134,665 07/25/23
Phan Ryan Thinh CSO & COO CSO & COO Jul 24 Buy 3.98 628 2,499 3,939 07/25/23
Parnell Winfred Director Director Jul 24 Buy 3.98 6,281 24,998 31,513 07/25/23
Merchant Minh Hoang General counsel and.. General counsel and secretary Jul 24 Buy 1.99 754 1,500 980 07/25/23
Jordan Veronica GH Director Director Jul 24 Buy 3.98 3,769 15,001 34,575 07/24/23
Hombeck Torsten Chief Financial Offi.. Chief Financial Officer Jul 24 Buy 3.98 754 3,001 754 07/24/23
Herchuk Jannie Prestridge Director Director Jul 24 Buy 3.98 8,794 35,000 23,833 07/24/23
Palmieri Valerie Barber Executive Chair Executive Chair May 16 Buy 0.5664 43,994 24,918 267,088 05/18/22
Sandford Nicole President and CEO President and CEO May 16 Buy 0.7642 98,000 74,892 136,160 05/17/22